iOnctura operates as a clinical-stage biotechnology company that specializes in developing a treatment for cancer.

Biotechnology

Health Care

Medical Devices

iOnctura

iOnctura's headquarters in Genève, Switzerland

Catherine Pickering

Peter Pokinskyj

Michael L.

Kiran Roest

Szilvia Bonhoure

Steven Sciuto

Lars Van Der Veen

Hakan Goker

Rachel Chambers

Stuart Farrow

Bart Vanhaesebroeck

James Larkin

Hendrik-Tobias Arkenau

Jordi Rodón Ahnert

Andrew Biankin

Thijs Cohen Tervaert

Anthony Mancini

Neil Gallagher

The Advisory Board at iOnctura comprises a diverse group of experts providing strategic guidance and insights on product development, clinical strategies, and market positioning for the company’s cancer treatment initiatives. Their collective expertise helps navigate regulatory landscapes, enhance research methodologies, and foster partnerships, ensuring that iOnctura remains at the forefront of innovation in the biotechnology sector.

Advisory Board

The Leadership Team at iOnctura plays a critical role in guiding the company's strategic direction in developing innovative cancer treatments. Comprising experts in clinical sciences, medical oversight, finance, and operations, the team collaborates to oversee research initiatives, manage resources, and ensure compliance with regulatory standards, while driving the overall mission to advance healthcare solutions for cancer patients.

Leadership Team

The Clinical and Research Operations team at iOnctura plays a crucial role in advancing the company's cancer treatment initiatives. This team is responsible for designing and managing clinical trials, ensuring compliance with regulatory standards, and overseeing the strategic development of research programs. Through collaboration with cross-functional teams and stakeholders, they aim to drive innovation and enhance the effectiveness of clinical programs to improve patient outcomes.

Clinical and Research Operations

The Research and Development team at iOnctura is dedicated to advancing innovative cancer therapies through rigorous scientific research and strategic development processes. Led by the CTO and including expertise from the Head of CMC and Head of Research, the team focuses on preclinical and clinical studies, biomanufacturing, and ensuring compliance with regulatory standards to bring promising treatments to patients.

Research and Development

iOnctura

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Clinical and Research Operations

Research and Development

Offices

iOnctura

Org chart

Board & advisors

Teams

Advisory Board

Leadership Team

Clinical and Research Operations

Research and Development

Offices

Related companies